Takeda strokes in Switzerland for up to 280 Points. The Japanese pharmaceutical company wants to move to the Takeover of Irish competitor Shire until the end of the year, the two companies Central Opfikon and train in Zurich Opfikon together.
Takeda had taken over the Shire at the beginning of the year to 62 billion dollars. The international headquarters of the Shire in train Takeda sweeps now 180 to 190 of 500 Points. The remaining Digits will be moved to Opfikon. A Takeda spokesman confirmed a corresponding report in the "NZZ" of Friday. He stressed that the Figures are estimates and these were not yet final.
Also at the European headquarters of Takeda in Opfikon 80 to 90 drop off of around 500 jobs. The consultation procedure with employee representatives started on Monday and lasts until November 27. May.
commitment to the Zurich Metropolitan area
For the employees concerned should there be a social plan. In addition, you should, if possible, alternative positions will be offered in the group. Already in the beginning of March, the media had reported about the merging of the sites.
Takeda is committed to Switzerland. The greater Zurich area is for the group as a strategic location for the business in Europe, wrote to Takeda in a statement.
in addition to train and Opfikon Takeda in Switzerland is represented with production sites in new castle and in Pfäffikon SZ. These are not affected by the job cuts. A total of around 1'500 people for the Japanese group working in Switzerland. Takeda developed especially anti-cancer drugs for the digestive tract, the nervous system and rare diseases.
Created: 17.05.2019, 11:59 PM